Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats
Crossref DOI link: https://doi.org/10.1007/s00540-015-2015-y
Published Online: 2015-05-01
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Erquan
Maruyama, Junko
Yokochi, Ayumu
Mitani, Yoshihide
Sawada, Hirofumi
Nishikawa, Masakatsu
Ma, Ning
Maruyama, Kazuo
Text and Data Mining valid from 2015-05-01